Stock NN6 NANOREPRO AG
Add to a list
To use this feature you must be a member
Log inSign up

Financials NanoRepro AG

Equities

NN6

DE0006577109

Medical Equipment, Supplies & Distribution

Market Closed - Xetra
Other stock markets
 11:36:10 2024-04-26 am EDT 		5-day change 1st Jan Change
1.845 EUR -0.27% Intraday chart for NanoRepro AG +6.03% -7.52%
2023 NanoRepro AG Reports Earnings Results for the Half Year Ended June 30, 2023 CI
2023 NanoRepro AG commences an Equity Buyback Plan for 10% of its issued share capital, under the authorization approved on April 29, 2022. CI

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 9.514 8.395 5.98 35.08 96.65 28.45
Enterprise Value (EV) 1 9.122 6.626 5.441 35.27 68.78 -2.807
P/E ratio -13 x -29 x -5.03 x 20.7 x 3.26 x -7.64 x
Yield - - - - 6.68% 6.8%
Capitalization / Revenue 4.83 x 3.05 x 3.31 x 2.07 x 0.59 x 0.73 x
EV / Revenue 4.63 x 2.41 x 3.01 x 2.08 x 0.42 x -0.07 x
EV / EBITDA -17.2 x 426 x -6.26 x 7.56 x 1.77 x 0.62 x
EV / FCF -7.67 x -12.8 x -7.65 x -6.54 x -9.85 x -0.14 x
FCF Yield -13% -7.82% -13.1% -15.3% -10.2% -724%
Price to Book 2.49 x 1.49 x 1.35 x 4.39 x 1.68 x 0.6 x
Nbr of stocks (in thousands) 6,840 8,480 8,482 9,331 12,904 12,904
Reference price 2 1.391 0.9900 0.7050 3.760 7.490 2.205
Announcement Date 4/11/18 3/28/19 5/25/20 5/21/21 6/13/22 5/4/23
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 1.972 2.749 1.806 16.93 162.7 38.79
EBITDA 1 -0.5306 0.0156 -0.8692 4.665 38.82 -4.525
EBIT 1 -0.7236 -0.3234 -1.181 4.653 38.81 -4.534
Operating Margin -36.7% -11.77% -65.43% 27.49% 23.85% -11.69%
Earnings before Tax (EBT) 1 -0.7339 -0.3306 -1.188 2.78 38.76 -4.364
Net income 1 -0.7341 -0.2896 -1.189 1.695 29.72 -3.724
Net margin -37.23% -10.54% -65.83% 10.01% 18.27% -9.6%
EPS 2 -0.1073 -0.0341 -0.1401 0.1817 2.300 -0.2886
Free Cash Flow 1 -1.189 -0.5184 -0.7108 -5.39 -6.983 20.32
FCF margin -60.3% -18.86% -39.37% -31.84% -4.29% 52.38%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - 0.5000 0.1500
Announcement Date 4/11/18 3/28/19 5/25/20 5/21/21 6/13/22 5/4/23
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - 0.19 - -
Net Cash position 1 0.39 1.77 0.54 - 27.9 31.3
Leverage (Debt/EBITDA) - - - 0.0403 x - -
Free Cash Flow 1 -1.19 -0.52 -0.71 -5.39 -6.98 20.3
ROE (net income / shareholders' equity) -21.4% -6.13% -23.7% 27.3% 90.6% -7.09%
ROA (Net income/ Total Assets) -11.7% -4.04% -13.9% 36.4% 53.7% -4.41%
Assets 1 6.258 7.166 8.539 4.655 55.34 84.53
Book Value Per Share 2 0.5600 0.6600 0.5200 0.8600 4.460 3.680
Cash Flow per Share 2 0.0800 0.2100 0.0900 0.1200 2.170 2.420
Capex 1 0 - - 0 0 0
Capex / Sales 0.19% - - 0% 0% 0%
Announcement Date 4/11/18 3/28/19 5/25/20 5/21/21 6/13/22 5/4/23
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
NANOREPRO AG Stock NanoRepro AG
-7.52% 25.37M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. NN6 Stock
  4. Financials NanoRepro AG